Treatment

Optimism for NK cell therapy as a future Alzheimer’s disease treatment

A benchmark for future disease-modifying therapies in Alzheimer’s disease

Testing anti-amyloid therapies in preclinical Alzheimer’s disease

The need for revised outcome measures in DLB trials

Time saved with Alzheimer’s disease therapeutics

Finding the ‘goldilocks’ zone for Alzheimer’s disease immunotherapies

The first network of multidomain dementia prevention: World-Wide FINGER trials

Manipulation of the immune system for Alzheimer’s disease therapy

Age-related variations in Alzheimer’s disease genetic risk associations

Digitally enhanced E-FINGER interventions for the prevention of dementia

Time saved in Alzheimer’s disease in Phase III trial of donanemab

Contextualizing the World-Wide FINGER trials in the real-world

Exercise as a non-pharmacological therapy for cognitive impairment

Immune activation states in Alzheimer’s disease mouse models

Natural killer cell integrity within Alzheimer’s disease

Current research into NK cell therapy and the potential for use in other conditions